OYE Therapeutics
Phase 1OYE's drug product can make treatment of opioid overdose (i.e. naloxone) safer, more effective, and more efficient, helping to shorten ER length of stay, reduce backlogs, and improve outcomes.
Founded
2020
Focus
OncologyImmunology
About
OYE's drug product can make treatment of opioid overdose (i.e. naloxone) safer, more effective, and more efficient, helping to shorten ER length of stay, reduce backlogs, and improve outcomes.
Funding History
1Total raised: $4.5M
Seed$4.5MUndisclosedMar 15, 2023
Company Info
TypePrivate
Founded2020
LocationCambridge, United States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile